New European patent approval for Episurf Medical
The European patent office EPO has announced its intention to grant another European patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “System and method for optimising an implant position in an anatomical joint”, covers parts of Episurf Medical’s technology for optimised design of the individualised Episealer® implants. "Episurf Medical’s Episealer® technology includes a number of details for optimised and efficient implant design, and this patent covers an important part thereof”, comments Katarina Flodström, COO, Episurf Medical. For more information, please contact: